EPCORE Trademark

Trademark Overview

On Wednesday, June 30, 2021, a trademark application was filed for EPCORE with the United States Patent and Trademark Office. The USPTO has given the EPCORE trademark a serial number of 90803984. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by AbbVie Biotechnology Ltd. The EPCORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
epcore

General Information

Serial Number90803984
Word MarkEPCORE
Filing DateWednesday, June 30, 2021
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7243375
Registration DateTuesday, December 12, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements

Pseudo MarkEP CORE
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 12, 2021
Primary Code042
First Use Anywhere DateFriday, November 13, 2020
First Use In Commerce DateFriday, November 13, 2020

Trademark Owner History

Party NameGENMAB A/S
Party Type31 - New Owner After Registration
Legal Entity Type65 - NOT AVAILABLE
AddressVALBY 2500
DK
Party NameAbbVie Biotechnology Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Saturday, July 3, 2021NEW APPLICATION ENTERED
Sunday, September 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 30, 2021ASSIGNED TO EXAMINER
Thursday, September 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022SOU EXTENSION 1 FILED
Thursday, June 30, 2022SOU EXTENSION 1 GRANTED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 2 FILED
Wednesday, December 14, 2022SOU EXTENSION 2 GRANTED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, June 28, 2023USE AMENDMENT FILED
Friday, July 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 21, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, November 3, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 4, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 8, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 8, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, April 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

epcore pharmaceuticals clinical trials field information medical scientific research providing